(Q44938493)

7 December 2017

title

Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients (English)

1 reference

7 December 2017

0 references

8

Björn Tackenberg

1 reference

7 December 2017

5

Christian Eienbröker

1 reference

7 December 2017

6

Wolfgang H Oertel

1 reference

7 December 2017

4

Dorothea Buck

1 reference

7 December 2017

Rebecca C Selter

1

1 reference

7 December 2017

Viola Biberacher

2

1 reference

7 December 2017

Verena Grummel

3

1 reference

7 December 2017

Achim Berthele

7

1 reference

7 December 2017

Bernhard Hemmer

9

1 reference

7 December 2017

language of work or name

1 reference

25 February 2013

1 reference

Multiple Sclerosis Journal

7 December 2017

published in

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

11

1 reference

7 December 2017

page(s)

1454-1461

1 reference

Regulation of lymphocyte traffic by adhesion molecules

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Integrin-dependence of lymphocyte entry into the splenic white pulp

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Integrin-mediated long-term B cell retention in the splenic marginal zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

A role for the VLA-4 integrin in the activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Follicular B helper T cells in antibody responses and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Differentiation and homing of IgA-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Immunological markers of optimal response to natalizumab in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513477229

21 January 2018

Identifiers

DOI

10.1177/1352458513477229

1 reference

7 December 2017

1 reference